$41.78
1.53% day before yesterday
NYSE, Jan 02, 10:08 pm CET
ISIN
US15135B1017
Symbol
CNC

Centene Stock price

$41.78
+2.97 7.65% 1M
+8.00 23.68% 6M
+0.63 1.53% YTD
-18.73 30.95% 1Y
-40.23 49.06% 3Y
-20.31 32.71% 5Y
+8.77 26.55% 10Y
+35.21 535.68% 20Y
NYSE, Closing price Fri, Jan 02 2026
+0.63 1.53%

New AI Insights on Centene Insights AI Insights on Centene

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$20.5b
Enterprise Value
$18.9b
Net debt
positive
Cash
$19.2b
Shares outstanding
491.4m
Valuation (TTM | estimate)
P/E
negative | 20.3
P/S
0.1 | 0.1
EV/Sales
0.1 | 0.1
EV/FCF
5.6
P/B
1.0
Financial Health
Equity Ratio
32.0%
Return on Equity
12.5%
ROCE
2.7%
ROIC
5.5%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$185.9b | $195.1b
EBITDA
$2.4b | $977.3m
EBIT
$1.1b | $207.5m
Net Income
$-5.3b | $1.0b
Free Cash Flow
$3.4b
Growth (TTM | estimate)
Revenue
14.9% | 19.6%
EBITDA
-44.5% | -78.4%
EBIT
-63.3% | -93.7%
Net Income
-272.5% | -69.5%
Free Cash Flow
1,621.0%
Margin (TTM | estimate)
Gross
8.1%
EBITDA
1.3% | 0.5%
EBIT
0.6%
Net
-2.9% | 0.5%
Free Cash Flow
1.8%
More
EPS
$-10.8
FCF per Share
$6.8
Short interest
2.9%
Employees
61k
Rev per Employee
$2.7m
Show more

Is Centene a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Centene Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Centene forecast:

7x Buy
27%
17x Hold
65%
2x Sell
8%

Analyst Opinions

26 Analysts have issued a Centene forecast:

Buy
27%
Hold
65%
Sell
8%

Financial data from Centene

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
185,857 185,857
15% 15%
100%
- Direct Costs 170,737 170,737
18% 18%
92%
15,120 15,120
10% 10%
8%
- Selling and Administrative Expenses 12,746 12,746
2% 2%
7%
- Research and Development Expense - -
-
-
2,374 2,374
44% 44%
1%
- Depreciation and Amortization 1,260 1,260
1% 1%
1%
EBIT (Operating Income) EBIT 1,114 1,114
63% 63%
1%
Net Profit -5,290 -5,290
272% 272%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Centene directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Centene Stock News

Neutral
GlobeNewsWire
16 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Centene (CNC) To Contact Him Directly To Discuss Their Options
Neutral
PRNewsWire
17 days ago
FORT LAUDERDALE, Fla. , Dec. 17, 2025 /PRNewswire/ -- Sunshine Health, a company of Centene Corporation (NYSE: CNC) and a leading managed care organization dedicated to improving the health and well-being of Floridians, announced it will partner with elite female athletes who are aligned with Sunshine Health's mission of improving the health of the community and who are motivated to help others...
Negative
Investors Business Daily
18 days ago
A last-ditch effort by GOP moderates to renew the subsidies may be on life support.
More Centene News

Company Profile

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Head office United States
CEO Sarah London
Employees 60,500
Founded 1984
Website www.centene.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today